Acknowledgment.
- Published in:
- BioDrugs, 2004, v. 18, n. 6, p. 349
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2004 AND VI 18 AND IP 6
Results: 7
1
2
Aptamers in Research and Drug Development.
- Published in:
- BioDrugs, 2004, v. 18, n. 6, p. 351, doi. 10.2165/00063030-200418060-00002
- By:
- Publication type:
- Article
3
Cellular Vehicles for Cancer Gene Therapy: Current Status and Future Potential.
- Published in:
- BioDrugs, 2004, v. 18, n. 6, p. 361, doi. 10.2165/00063030-200418060-00003
- By:
- Publication type:
- Article
4
Recent Trends and Advances in Immunodiagnostics of Solid Tumors.
- Published in:
- BioDrugs, 2004, v. 18, n. 6, p. 387, doi. 10.2165/00063030-200418060-00004
- By:
- Publication type:
- Article
5
Regulation of Biogenerics: A Survey of Viewpoints.
- Published in:
- BioDrugs, 2004, v. 18, n. 6, p. 399, doi. 10.2165/00063030-200418060-00005
- By:
- Publication type:
- Article
6
Interleukin-2 Plus Ribavirin Versus Interferon-α-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-α-2b Treatment.
- Published in:
- BioDrugs, 2004, v. 18, n. 6, p. 407, doi. 10.2165/00063030-200418060-00006
- By:
- Publication type:
- Article
7
Spotlight on Omalizumab in Allergic Asthma.
- Published in:
- BioDrugs, 2004, v. 18, n. 6, p. 415, doi. 10.2165/00063030-200418060-00007
- By:
- Publication type:
- Article